ArticleHypertension (Dallas, Tex. : 1979)2022

Mineralocorticoid Receptor Antagonist Use and Hard Renal Outcomes in Real-World Patients With Chronic Kidney Disease.

Tatsufumi Oka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.